Dual bronchodilation for the treatment of COPD: from bench to bedside
M Cazzola, C Page, P Rogliani… - British Journal of …, 2022 - Wiley Online Library
Because there is a solid pharmacological rationale based on positive interactions between
long‐acting muscarinic receptor antagonists (LAMAs) and long‐acting β‐agonists (LABAs) …
long‐acting muscarinic receptor antagonists (LAMAs) and long‐acting β‐agonists (LABAs) …
[HTML][HTML] Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review
Chronic obstructive pulmonary disease (COPD) constitutes a major global health burden
and is the third leading cause of death worldwide. A high proportion of patients with COPD …
and is the third leading cause of death worldwide. A high proportion of patients with COPD …
[HTML][HTML] Umeclidinio/vilanterolo nel trattamento farmacologico della BPCO
M Cazzola, P Rogliani, L Calzetta… - Rassegna di Patologia …, 2022 - aiporassegna.it
Un solido razionale farmacologico, una marcata sinergia d'azione documentata sulle vie
aeree umane in vitro e un'eccellente efficacia clinica emersa dagli studi randomizzati …
aeree umane in vitro e un'eccellente efficacia clinica emersa dagli studi randomizzati …